Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage. The company's biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. It offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Atozet, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for treatments of control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. The company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. It sells its products to drug wholesalers and retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. The company was incorporated in 2020 and is headquartered in Jersey City, New Jersey. more
Time Frame | OGN | Sector | S&P500 |
---|---|---|---|
1-Week Return | 2.08% | -1.8% | -0.77% |
1-Month Return | -2.55% | -3.48% | 0.71% |
3-Month Return | -22.22% | -7.2% | 8.81% |
6-Month Return | -22.61% | -1.54% | 12.32% |
1-Year Return | 39.63% | 8.39% | 30.57% |
3-Year Return | -45.69% | 6.07% | 29.21% |
5-Year Return | -52.84% | 44.07% | 91.95% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 7.78B | 8.10B | 6.30B | 6.17B | 6.26B | [{"date":"2019-12-31","value":96.06,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":77.87,"profit":true},{"date":"2022-12-31","value":76.26,"profit":true},{"date":"2023-12-31","value":77.36,"profit":true}] |
Cost of Revenue | 2.27B | 3.35B | 2.38B | 2.29B | 2.52B | [{"date":"2019-12-31","value":67.94,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":71.17,"profit":true},{"date":"2022-12-31","value":68.54,"profit":true},{"date":"2023-12-31","value":75.14,"profit":true}] |
Gross Profit | 5.50B | 4.75B | 3.92B | 3.88B | 3.75B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":86.3,"profit":true},{"date":"2021-12-31","value":71.27,"profit":true},{"date":"2022-12-31","value":70.51,"profit":true},{"date":"2023-12-31","value":68.11,"profit":true}] |
Gross Margin | 70.76% | 58.66% | 62.21% | 62.84% | 59.84% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":82.9,"profit":true},{"date":"2021-12-31","value":87.92,"profit":true},{"date":"2022-12-31","value":88.81,"profit":true},{"date":"2023-12-31","value":84.57,"profit":true}] |
Operating Expenses | 1.66B | 1.97B | 2.11B | 2.17B | 2.42B | [{"date":"2019-12-31","value":68.69,"profit":true},{"date":"2020-12-31","value":81.37,"profit":true},{"date":"2021-12-31","value":87.2,"profit":true},{"date":"2022-12-31","value":89.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 3.85B | 2.85B | 1.62B | 1.48B | 1.33B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":74.06,"profit":true},{"date":"2021-12-31","value":42.08,"profit":true},{"date":"2022-12-31","value":38.42,"profit":true},{"date":"2023-12-31","value":34.49,"profit":true}] |
Total Non-Operating Income/Expense | (151.00M) | (95.00M) | (644.00M) | (1.00B) | (1.17B) | [{"date":"2019-12-31","value":-15100000000,"profit":false},{"date":"2020-12-31","value":-9500000000,"profit":false},{"date":"2021-12-31","value":-64400000000,"profit":false},{"date":"2022-12-31","value":-100500000000,"profit":false},{"date":"2023-12-31","value":-117100000000,"profit":false}] |
Pre-Tax Income | 3.70B | 2.68B | 1.53B | 1.12B | 673.00M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":72.51,"profit":true},{"date":"2021-12-31","value":41.37,"profit":true},{"date":"2022-12-31","value":30.36,"profit":true},{"date":"2023-12-31","value":18.21,"profit":true}] |
Income Taxes | 390.00M | 520.00M | 178.00M | 205.00M | (350.00M) | [{"date":"2019-12-31","value":75,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":34.23,"profit":true},{"date":"2022-12-31","value":39.42,"profit":true},{"date":"2023-12-31","value":-67.31,"profit":false}] |
Income After Taxes | 3.31B | 2.16B | 1.35B | 917.00M | 1.02B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":65.34,"profit":true},{"date":"2021-12-31","value":40.87,"profit":true},{"date":"2022-12-31","value":27.74,"profit":true},{"date":"2023-12-31","value":30.94,"profit":true}] |
Income From Continuous Operations | 3.22B | 2.16B | 1.35B | 917.00M | 585.00M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":67.12,"profit":true},{"date":"2021-12-31","value":41.98,"profit":true},{"date":"2022-12-31","value":28.5,"profit":true},{"date":"2023-12-31","value":18.18,"profit":true}] |
Income From Discontinued Operations | (88.00M) | (96.00M) | - | - | - | [{"date":"2019-12-31","value":-8800000000,"profit":false},{"date":"2020-12-31","value":-9600000000,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 3.22B | 2.16B | 1.35B | 917.00M | 1.02B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":67.12,"profit":true},{"date":"2021-12-31","value":41.98,"profit":true},{"date":"2022-12-31","value":28.5,"profit":true},{"date":"2023-12-31","value":31.79,"profit":true}] |
EPS (Diluted) | - | - | 6.34 | 5.03 | 4.14 | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":79.34,"profit":true},{"date":"2023-12-31","value":65.3,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
OGN | |
---|---|
Cash Ratio | 0.27 |
Current Ratio | 1.70 |
Quick Ratio | 1.21 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
OGN | |
---|---|
ROA (LTM) | 7.91% |
ROE (LTM) | 0.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
OGN | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.96 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.04 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
OGN | |
---|---|
Trailing PE | 2.99 |
Forward PE | 5.03 |
P/S (TTM) | 0.61 |
P/B | 7.90 |
Price/FCF | 60 |
EV/R | 1.85 |
EV/Ebitda | 7.62 |
Organon & Co (OGN) share price today is $15.68
Yes, Indians can buy shares of Organon & Co (OGN) on Vested. To buy Organon & Co from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Organon & Co (OGN) via the Vested app. You can start investing in Organon & Co (OGN) with a minimum investment of $1.
You can invest in shares of Organon & Co (OGN) via Vested in three simple steps:
The 52-week high price of Organon & Co (OGN) is $22.7. The 52-week low price of Organon & Co (OGN) is $11.88.
The price-to-earnings (P/E) ratio of Organon & Co (OGN) is 2.9802
The price-to-book (P/B) ratio of Organon & Co (OGN) is 7.90
The dividend yield of Organon & Co (OGN) is 7.41%
The market capitalization of Organon & Co (OGN) is $3.88B
The stock symbol (or ticker) of Organon & Co is OGN